Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.
Researchers in the Baker Institute for Animal Health have created a genetically engineered mouse model that could shed light on the causes of human infertility and allow researchers to explore other areas of reproduction.
A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.
A pair of researchers in the Department of Neurobiology and Behavior are designing new technology and research methods to discover how brain circuits support learning and memory.
A new method could be used by biologists to estimate the prevalence of disease in free-ranging wildlife and help determine how many samples are needed to detect a disease.
The inflammatory response from adaptive immune cells – such as B and T lymphocytes – clears the body of the SARS-CoV-2 virus, but at the same time, it also causes the characteristic symptoms of COVID-19, a new study finds.
By teasing out the biological mechanisms in pregnancy-related mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat pregnant women and new mothers at risk.
Weill Cornell researchers find inflammatory bowel disease drug works by modulating the activity of a group of gut bacteria that are more abundant in patients who respond to the drug.
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.